Why the study?
Risk stratification for thromboembolism is critical in AF, prompting assessment of thromboembolism risk groups and management indications.
Cross-Sectional (n=150)
No
The study highlights a significant gap in clinical practice, with severe under-prescription of oral anticoagulation in atrial fibrillation patients at high and very high risk for thromboembolism.
Alerts clinicians to anticoagulation gaps in high-risk permanent AF; leaves open whether targeted interventions improve uptake.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Muryatha Khuther Hmoud (2024) conducted a cross-sectional in Permanent atrial fibrillation (n=150). Warfarin vs. No treatment was evaluated on Warfarin prescription rate in very high risk AF patients (p=0.035).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: